NCT01562288View on ClinicalTrials.gov

Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab

CompletedOBSERVATIONAL
Enrollment

1,576

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Breast Cancer
Interventions
GENETIC

DNA analysis

GENETIC

gene expression analysis

GENETIC

polymerase chain reaction

OTHER

enzyme-linked immunosorbent assay

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT01562288 - Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab | Biotech Hunter | Biotech Hunter